A Genome-Wide Aberrant RNA Splicing in Patients with Acute Myeloid Leukemia Identifies Novel Potential Disease Markers and Therapeutic Targets
Lists
Only you see this
Abstract
Overall, our results suggest that aberrant splicing is a common characteristic for AML. Our findings also suggest that splice variant transcripts that are the result of splicing aberrations create novel disease markers and provide potential targets for small molecules or antibody therapeutics for this disease.
BibTeX
@inproceedings{adamia2013genome,
author = {Sophia Adamia and Benjamin Haibe‐Kains and Patrick M. Pilarski and Michal Bar‐Natan and Samuel Pevzner and Hervé Avet‐Loiseau and Laurence Lodé and Sigitas Verselis and Edward A. Fox and John P. Burke and Ilene Galinsky and Ibiayi Dagogo‐Jack and Martha Wadleigh and David P. Steensma and Gabriela Motyckova and Daniel J. DeAngelo and John Quackenbush and Richard M. Stone and James D. Griffin},
title = {{A Genome-Wide Aberrant RNA Splicing in Patients with Acute Myeloid Leukemia Identifies Novel Potential Disease Markers and Therapeutic Targets}},
booktitle = {Clinical},
year = {2013},
doi = {10.1158/1078-0432.ccr-13-0956},
}Loading related content...